T1	Disorder 28 52	myelodysplastic syndrome
N1 	Reference T1 UMLS:C3463824	myelodysplastic syndrome
T2	Pharmacological_substance 59 71	temozolomide
N1000 	Reference T2 MeSH:C047246	temozolomide
T3	Disorder 76 103	recurrent high-grade glioma
N2 	Reference T3 UMLS:C0017638	recurrent high-grade glioma
T4	Disorder 123 149	recurrent malignant glioma
N3 	Reference T4 UMLS:C0017638	recurrent malignant glioma
T5	Disorder 169 193	myelodysplastic syndrome
N4 	Reference T5 UMLS:C3463824	myelodysplastic syndrome
T6	Disorder 206 220	acute leukemia
N5 	Reference T6 UMLS:C0085669	acute leukemia
T7	Disorder 342 378	refractory anemia with excess blasts
N6 	Reference T7 UMLS:C0002894	refractory anemia with excess blasts
T8	Disorder 403 435	recurrent anaplastic astrocytoma
N7 	Reference T8 UMLS:C0004114	recurrent anaplastic astrocytoma
T9	Pharmacological_substance 441 453	temozolomide
N1001 	Reference T9 MeSH:C047246	temozolomide
T10	Disorder 587 601	acute leukemia
N8 	Reference T10 UMLS:C0085669	acute leukemia
T11	Disorder 830 838	toxicity
N9 	Reference T11 UMLS:C0600688	toxicity
T15	Pharmacological_substance 455 458	TMZ
N1002 	Reference T15 MeSH:C047246	TMZ
T16	Pharmacological_substance 549 552	TMZ
N1003 	Reference T16 MeSH:C047246	TMZ
T13	Subject 109 117	patients
T14	Subject 310 329	a 44-year-old woman
T18	Pharmacological_substance 783 786	TMZ
N1004 	Reference T18 MeSH:C047246	TMZ
T23	Disorder 335 340	t-MDS
N10 	Reference T23 UMLS:C1292780	t-MDS
T26	Disorder 636 639	MDS
N11 	Reference T26 UMLS:C3463824	MDS
T27	Disorder 724 729	t-MDS
N12 	Reference T27 UMLS:C1292780	t-MDS
T25	Disorder 504 507	MDS
N13 	Reference T25 UMLS:C3463824	MDS
T28	Manner_cue 225 229	rare
T21	Disorder 488 502	del (3)(q11.1)
T29	Disorder 657 661	died
N14 	Reference T29 UMLS:C1546956	died
N15 	Reference T29 UMLS:C1306577	died
T30	Coreferring_mention 151 160	treatment
